These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 20453640

  • 1. Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry.
    Siudak Z, Zawislak B, Dziewierz A, Rakowski T, Jakala J, Bartus S, Noworolnik B, Zasada W, Dubiel JS, Dudek D.
    Coron Artery Dis; 2010 Aug; 21(5):292-7. PubMed ID: 20453640
    [Abstract] [Full Text] [Related]

  • 2. Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center.
    Barthélémy O, Silvain J, Brieger D, Mercadier A, Lancar R, Bellemain-Appaix A, Beygui F, Collet JP, Costagliola D, Montalescot G.
    Catheter Cardiovasc Interv; 2012 Jan 01; 79(1):104-12. PubMed ID: 22162411
    [Abstract] [Full Text] [Related]

  • 3. Comparison of transradial vs. transfemoral approach in the treatment of acute myocardial infarction with primary angioplasty and abciximab.
    Philippe F, Larrazet F, Meziane T, Dibie A.
    Catheter Cardiovasc Interv; 2004 Jan 01; 61(1):67-73. PubMed ID: 14696162
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of the transradial approach to reduce bleedings in patients undergoing urgent coronary angioplasty with GPIIb/IIIa inhibitors for acute coronary syndromes.
    De Carlo M, Borelli G, Gistri R, Ciabatti N, Mazzoni A, Arena M, Petronio AS.
    Catheter Cardiovasc Interv; 2009 Sep 01; 74(3):408-15. PubMed ID: 19360863
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of door-to-balloon times for primary PCI using transradial versus transfemoral approach.
    Pancholy S, Patel T, Sanghvi K, Thomas M, Patel T.
    Catheter Cardiovasc Interv; 2010 Jun 01; 75(7):991-5. PubMed ID: 20517957
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Radial vs femoral approach with StarClose clip placement for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. RADIAMI II: a prospective, randomised, single centre trial.
    Chodór P, Kurek T, Kowalczuk A, Świerad M, Wąs T, Honisz G, Świątkowski A, Streb W, Kalarus Z.
    Kardiol Pol; 2011 Jun 01; 69(8):763-71. PubMed ID: 21850615
    [Abstract] [Full Text] [Related]

  • 12. Impact of infarct related artery patency after early abciximab administration on one-year mortality in patients with ST-segment elevation myocardial infarction (data from the EUROTRANSFER Registry).
    Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Janzon M, Mielecki W, Zmudka K, Dubiel JS, Dudek D.
    Kardiol Pol; 2012 Jun 01; 70(3):215-21. PubMed ID: 22430397
    [Abstract] [Full Text] [Related]

  • 13. Radial versus femoral access for primary percutaneous interventions in ST-segment elevation myocardial infarction patients: a meta-analysis of randomized controlled trials.
    Karrowni W, Vyas A, Giacomino B, Schweizer M, Blevins A, Girotra S, Horwitz PA.
    JACC Cardiovasc Interv; 2013 Aug 01; 6(8):814-23. PubMed ID: 23968700
    [Abstract] [Full Text] [Related]

  • 14. Influence of arterial access site selection on outcomes in primary percutaneous coronary intervention: are the results of randomized trials achievable in clinical practice?
    Mamas MA, Ratib K, Routledge H, Neyses L, Fraser DG, de Belder M, Ludman PF, Nolan J, British Cardiovascular Intervention Society and the National Institute for Cardiovascular Outcomes Research.
    JACC Cardiovasc Interv; 2013 Jul 01; 6(7):698-706. PubMed ID: 23769648
    [Abstract] [Full Text] [Related]

  • 15. Early abciximab administration before transfer for primary percutaneous coronary interventions for ST-elevation myocardial infarction reduces 1-year mortality in patients with high-risk profile. Results from EUROTRANSFER registry.
    Rakowski T, Siudak Z, Dziewierz A, Birkemeyer R, Legutko J, Mielecki W, Depukat R, Janzon M, Stefaniak J, Zmudka K, Dubiel JS, Partyka L, Dudek D.
    Am Heart J; 2009 Oct 01; 158(4):569-75. PubMed ID: 19781416
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Rapid cycle change to predominantly radial access coronary angiography and percutaneous coronary intervention: effect on vascular access site complications.
    Nadarasa K, Robertson MC, Wong CK, Green BK, Chen VH, Wilkins GT, Williams MJ.
    Catheter Cardiovasc Interv; 2012 Mar 01; 79(4):589-94. PubMed ID: 21523899
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long term efficacy of abciximab bolus-only compared to abciximab bolus and infusion after transradial coronary stenting.
    Bagur R, Bertrand OF, Rodés-Cabau J, Larose E, Rinfret S, Nguyen CM, Noel B, Larochellière RD, Poirier P, Costerousse O, Roy L.
    Catheter Cardiovasc Interv; 2009 Dec 01; 74(7):1010-6. PubMed ID: 19753635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.